Arteris, Inc. (AIP) Q2 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call reveals strong financial performance with a 13% increase in revenue and a 15% rise in ACV plus royalties, reflecting growing demand. Record high revenue and strategic wins with major clients like AMD are positive indicators. While there are some concerns about expenses, the optimistic guidance for revenue and cash flow, alongside strategic partnerships and product developments, suggests a positive outlook. However, the lack of clarity on certain metrics in the Q&A slightly tempers enthusiasm, but the overall sentiment remains positive, likely leading to a stock price increase of 2% to 8%.
Key Financial Performance
Total Revenue $16.5 million, up 13% year-over-year. The increase was driven by strong deal execution and growing demand for system IP technology.
Annual Contract Value (ACV) plus Royalties $69.1 million, up 15% year-over-year. This growth reflects increased adoption of Arteris' technology, particularly in enterprise computing and automotive applications.
Remaining Performance Obligations (RPO) $99.3 million, representing a 28% year-over-year increase. This highlights the growing demand for Arteris' system IP technology.
Non-GAAP Gross Profit $15 million, representing a gross margin of 91%. This was driven by efficient cost management and strong revenue growth.
GAAP Gross Profit $14.8 million, representing a gross margin of 89%. This aligns closely with the non-GAAP gross profit, reflecting consistent financial performance.
Non-GAAP Operating Expense $18.6 million, 10% higher year-over-year. The increase was due to scaling investments in R&D and field application engineering teams.
GAAP Operating Expense $23 million, representing a 12% year-over-year increase. This was driven by strategic investments in new product development and customer support.
Non-GAAP Operating Loss $3.5 million, flat year-over-year. This reflects controlled spending and efficient operations.
GAAP Operating Loss $8.2 million, compared to a loss of $7.4 million in the prior year period. The increase was influenced by higher operating expenses.
Non-GAAP Net Loss $4.4 million or $0.11 per share. This was in line with guidance and reflects ongoing investments in growth initiatives.
GAAP Net Loss $9.1 million or $0.22 per share. This was higher than the prior year due to increased operating expenses.
Free Cash Flow Negative $2.8 million. This was approximately at the midpoint of guidance and reflects capital expenditures and operational investments.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
FlexGen adoption: AMD, a global leader in high-performance computing, signed an agreement to utilize Arteris FlexGen technology for AI applications. Over two dozen FlexGen installations are now operational, and the product is expected to contribute to revenue over time.
Magillem Packaging: A new software product designed to automate IP packaging, simplifying and speeding up the process of assembling silicon chiplets and chips. It aims to reduce errors and delays in integrating IP blocks.
AI-driven market expansion: Increased adoption of Arteris technology in enterprise computing and automotive applications, driven by AI computing needs. Strategic wins include AMD and Whalechip, a fabless semiconductor provider.
Multi-die solution expansion: Expanded support for Universal Chiplet Interconnect Express (UCIe), Arm AMBA protocols, and collaborations with Synopsys, Cadence, and RISC-V ecosystem partners. This supports the shift towards multi-die or chiplet architectures in AI applications.
Revenue growth: Total revenue for Q2 2025 was $16.5 million, up 13% year-over-year.
Record performance metrics: Annual contract value plus royalties reached $69.1 million, a 15% year-over-year increase. Remaining performance obligations were $99.3 million, up 28% year-over-year.
Customer outsourcing trend: Major customers are increasingly outsourcing system IP needs to Arteris to accelerate time-to-market, reduce costs, and improve operational efficiencies.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Global Economic Uncertainty: The company is monitoring global economic uncertainty, which could potentially impact deal cancellations or delays in the future, even though it did not affect the second quarter.
Foreign Exchange Fluctuations: The weakening U.S. dollar, especially against the euro, has increased operating expenses and could continue to impact financial performance if exchange rates remain unfavorable.
Rising Operating Expenses: Operating expenses have increased due to scaling investments in R&D, customer support, and sales expansion, which could pressure profitability if revenue growth does not keep pace.
Complexity of Multi-Die SoCs: The increasing complexity of multi-die SoCs and the need for reliable integration of numerous IP blocks could lead to costly errors and delays if not managed effectively.
Dependence on Key Customers: The company’s growth is tied to relationships with major customers like AMD and Renesas. Any disruption in these relationships could adversely affect revenue.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Third Quarter 2025 Guidance: ACV plus royalties expected to range from $69.5 million to $72.5 million. Revenue projected between $16.8 million and $17.2 million. Non-GAAP operating loss anticipated to be between $3 million and $4 million. Non-GAAP free cash flow expected to range from $0.5 million to $3.5 million.
Full Year 2025 Guidance: ACV plus royalties projected to exit 2025 at $72 million to $78 million. Revenue expected to range from $66 million to $70 million. Non-GAAP operating loss forecasted between $10.5 million and $15.5 million. Non-GAAP free cash flow anticipated to range from $1 million to $7 million.
Foreign Exchange Impact: Operating expenses are higher than expected due to the weakening U.S. dollar, particularly against the euro. Guidance assumes current foreign exchange rates remain stable for the rest of 2025.
Customer Trends and Outsourcing: Promising signs of increased interest from major customers to outsource system IP products to Arteris, potentially accelerating product time-to-market and improving operational efficiencies.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Can you share details on the scope of the AMD announcement and how AMD is using your IP?
A:In February, the FlexGen product was announced, offering higher productivity and advantages in PPA in terms of wire length. AMD extensively evaluated this product and chose it as the best option after benchmarking against competitors. They decided to apply it to various products, including AI data center chiplets.
Q:How should we think about the timeline and magnitude of the AMD deal's impact on the model?
A:The AMD deal was already included in the guidance provided at the end of the first quarter. It is one of the major deals secured annually, and the company typically has one or two such deals per quarter. The deal was already contemplated in the previous guidance.
Q:Was AMD's decision influenced by their internal NoC team or performance metrics?
A:AMD decided to continue using their internal cache-coherent fabric (Infinity Fabric) and augment it with Arteris technology for non-coherent applications. It was a mix-and-match approach rather than a performance issue.
Q:What steps are being taken to accelerate customer adoption of FlexGen?
A:FlexGen involves changes in methodologies, and evaluations vary in speed. There are over two dozen ongoing evaluations, and sales are anticipated to start in the second half of the year, in addition to the AMD deal. AMD's validation of the technology is expected to help accelerate adoption.
Q:Is the AMD deal primarily for chiplet implementations or heterogeneous implementations?
A:The deal covers a variety of products, including AI-oriented chiplet SoCs. It is a multi-license deal, and chiplets are one of the key applications.
Q:How many heterogeneous chiplet projects are currently active?
A:There are about 600 to 700 SoCs, with approximately 30 active heterogeneous chiplet projects, representing about 5% of the total. This is expected to grow to 30% of overall SoC design starts in the next few years.
Q:What is the book-to-bill ratio for the quarter?
A:The book-to-bill ratio is not specifically monitored, but the RPO (backlog of future revenue) grew to nearly $100 million, a 28% year-over-year increase, indicating positive growth.
Q:Review of Unclear Management Responses
A:Management avoided directly commenting on the book-to-bill ratio, stating that it is not specifically monitored. The response lacked clarity and specific data on this metric.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
AI AMD
AI Breakthrough
AI Engineering
AI center
AI era
AMBA protocol
AMD Infinity
AMD chiplets
AMD leader
AMD portfolio
AMD relationship
ASICs processor
Andes SiFive
Arm AMBA
Award nomination
Awards FlexGen
Breakthrough Awards
Bryan Hawkins
Buchalter TD
CEO President
IP block
Inc
Janac
Renesas
Research Division
collaboration
complexity
delay
efficiency AI
interconnect
movement
number IP
others
security
solution
transport
win
AIP Transcript
Arteris, Inc. (AIP) Q1 2026 Earnings Call Transcript
Positive5-12
The earnings call highlights positive financial performance, with a 12% YoY revenue increase and improved gross margins. Despite a net loss, the reduction compared to the previous year and positive cash flow indicate a strengthening financial position. The guidance suggests potential profitability by Q4 2026, further supporting a positive outlook. However, the absence of strategic initiatives and operational updates tempers the enthusiasm, leading to a moderate positive sentiment.
Arteris, Inc. (AIP) Q4 2025 Earnings Call Transcript
Positive2-12
The earnings call highlights strong financial performance with significant revenue growth, improved operating losses, and positive cash flow. The Q&A section reveals increased customer interest in comprehensive solutions, boosting licensing ASPs. Despite a potential negative from equity raising, the overall sentiment remains positive due to strong financial metrics, optimistic guidance, and strategic collaborations.
Arteris, Inc. (AIP) Q3 2025 Earnings Call Transcript
Positive11-4
The earnings call summary shows strong financial performance with significant revenue growth, high gross margins, and positive free cash flow. The Q&A highlights opportunities with major companies like AMD and Altera, and the focus on AI and data centers is promising. The management's avoidance of booking details is a minor concern, but overall, the optimistic guidance, strong partnerships, and strategic investments suggest a positive outlook for the stock price.
Arteris, Inc. (AIP) Q2 2025 Earnings Call Transcript
Positive8-5
The earnings call reveals strong financial performance with a 13% increase in revenue and a 15% rise in ACV plus royalties, reflecting growing demand. Record high revenue and strategic wins with major clients like AMD are positive indicators. While there are some concerns about expenses, the optimistic guidance for revenue and cash flow, alongside strategic partnerships and product developments, suggests a positive outlook. However, the lack of clarity on certain metrics in the Q&A slightly tempers enthusiasm, but the overall sentiment remains positive, likely leading to a stock price increase of 2% to 8%.
AIP Slides
AIP Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
